Iron Chelation Therapy in Hereditary Hemochromatosis and Thalassemia Intermedia: Regulatory and Non Regulatory Mechanisms of Increased Iron Absorption-Reference-Cited by-同舟云学术

Iron Chelation Therapy in Hereditary Hemochromatosis and Thalassemia Intermedia: Regulatory and Non Regulatory Mechanisms of Increased Iron Absorption

Published:2010-06 Issue:3 Volume:34 Page:251-264
ISSN:0363-0269
Container-title:Hemoglobin
language:en
Short-container-title:Hemoglobin

Author:

Kontoghiorghes George J.,Spyrou Aspasia,Kolnagou Annita

Publisher

Informa UK Limited

Subject

Biochemistry, medical,Clinical Biochemistry,Genetics(clinical),Hematology

Link

http://www.tandfonline.com/doi/pdf/10.3109/03630269.2010.486335

Reference28 articles.

1. A novel MHC class I–like gene is mutated in patients with hereditary haemochromatosis

2. Hemochromatosis

3. Molecular Factors and Mechanisms Affecting Iron and Other Metal Excretion or Absorption in Health and Disease. The Role of Natural and Synthetic Chelators

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Importance and Essentiality of Natural and Synthetic Chelators in Medicine: Increased Prospects for the Effective Treatment of Iron Overload and Iron Deficiency;International Journal of Molecular Sciences;2024-04-25

2. Paroxysmal atrial fibrillation and hemochromatosis: a narrative review;Annals of Medicine & Surgery;2023-12-05

3. Iron Load Toxicity in Medicine: From Molecular and Cellular Aspects to Clinical Implications;International Journal of Molecular Sciences;2023-08-18

4. Deferiprone and Iron–Maltol: Forty Years since Their Discovery and Insights into Their Drug Design, Development, Clinical Use and Future Prospects;International Journal of Molecular Sciences;2023-03-04

5. New Iron Metabolic Pathways and Chelation Targeting Strategies Affecting the Treatment of All Types and Stages of Cancer;International Journal of Molecular Sciences;2022-11-13